🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Mohamed Abu‐Farha

Dasman Diabetes Institute

ORCID: 0000-0001-8357-1252
Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Distinct Mechanisms Responsible for the Increase in Glucose Production and Ketone Formation Caused by Empagliflozin in T2DM Patients”.

Distinct Mechanisms Responsible for the Increase in Glucose Production and Ketone Formation Caused by Empagliflozin in T2DM Patients

Diabetes Care(2023)10.2337/dc22-0885
N/A
0DataRank · unranked
26 citations

Ahmed Khattab, John M. Adams, Mohamed Abu‐Farha, Giuseppe Daniele, Fahd Al‐Mulla +4 more

Plasma insulin is required for the increase in plasma angiopoietin‐like protein 8 in response to nutrient ingestion

Diabetes/Metabolism Research and Reviews(2023)10.1002/dmrr.3643
N/A
0DataRank · unranked
5 citations

Mariam Alatrach, Jehad Abubaker, Irina Al‐Khairi, Preethi Cherian, Krisitn Agyin +9 more

Unraveling Verapamil's Multidimensional Role in Diabetes Therapy: From β-Cell Regeneration to Cholecystokinin Induction

Preprints.org(2024)10.20944/preprints202403.1681.v1
N/A
0DataRank · unranked
0 citations

Ashraf Al Madhoun, Fatema Al‐Rashed, Fawaz Alzaïd, Fatemah Bahman, Rasheeba Nizam +18 more

Empagliflozin Enhances Hepatic Glucose Production and Reduces Total-Body Norepinephrine Turnover Rate: A Randomized Trial

Diabetes(2025)10.2337/db25-0210
N/A
0DataRank · unranked
0 citations

Ahmed A. Khattab, John M. Adams, Fahd Al‐Mulla, Mohamed Abu‐Farha, Gozde Baskoy +6 more